124 related articles for article (PubMed ID: 9169966)
21. Pharmacodynamic response profiles of anxiolytic and sedative drugs.
Chen X; Broeyer F; de Kam M; Baas J; Cohen A; van Gerven J
Br J Clin Pharmacol; 2017 May; 83(5):1028-1038. PubMed ID: 27922194
[TBL] [Abstract][Full Text] [Related]
22. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers.
Venkatakrishnan K; Culm KE; Ehrenberg BL; Harmatz JS; Corbett KE; Fleishaker JC; Greenblatt DJ
J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776
[TBL] [Abstract][Full Text] [Related]
23. Ambulatory accelerometry to quantify motor behaviour in patients after failed back surgery: a validation study.
Bussmann JB; van de Laar YM; Neeleman MP; Stam HJ
Pain; 1998 Feb; 74(2-3):153-61. PubMed ID: 9520229
[TBL] [Abstract][Full Text] [Related]
24. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
Mumford GK; Rush CR; Griffiths RR
J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
[TBL] [Abstract][Full Text] [Related]
25. Effects of lorazepam on film-induced differentiated emotions in healthy volunteers.
Garcia C; Philippot P; Lacarelle B; Valli M; Rimé B; Bruguerolle B; Blin O
Fundam Clin Pharmacol; 1997; 11(5):466-75. PubMed ID: 9342601
[TBL] [Abstract][Full Text] [Related]
26. Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep.
Subhan Z; Harrison C; Hindmarch I
Eur J Clin Pharmacol; 1986; 29(6):709-12. PubMed ID: 3709614
[TBL] [Abstract][Full Text] [Related]
27. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.
Hindmarch I; Gudgeon AC
Br J Clin Pharmacol; 1980 Aug; 10(2):145-50. PubMed ID: 6107116
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam.
Fries E; Hellhammer DH; Hellhammer J
Psychoneuroendocrinology; 2006 Nov; 31(10):1278-88. PubMed ID: 17097811
[TBL] [Abstract][Full Text] [Related]
29. Effects of 1 week administration of two benzodiazepines on the sleep and early daytime performance of normal subjects.
Jurado JL; Fernández-Mas R; Fernández-Guardiola A
Psychopharmacology (Berl); 1989; 99(1):91-3. PubMed ID: 2506608
[TBL] [Abstract][Full Text] [Related]
30. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
[TBL] [Abstract][Full Text] [Related]
31. Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.
Bourin M; Hascoet M; Mansouri B; Colombel MC; Bradwejn J
J Psychiatry Neurosci; 1992 Jun; 17(2):72-7. PubMed ID: 1637802
[TBL] [Abstract][Full Text] [Related]
32. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
33. In vivo effects of alprazolam and lorazepam on the immune response in patients with migraine without aura.
Covelli V; Maffione AB; Greco B; Cannuscio B; Calvello R; Jirillo E
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):415-28. PubMed ID: 8227969
[TBL] [Abstract][Full Text] [Related]
34. The effects of lorazepam on skin conductance responses to aversive stimuli in healthy subjects.
Siepmann M; Heine B; Kluge A; Ziemssen T; Mück-Weymann M; Kirch W
Clin Auton Res; 2007 Jun; 17(3):160-4. PubMed ID: 17390103
[TBL] [Abstract][Full Text] [Related]
35. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
van Laar M; Volkerts E; Verbaten M
Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
[TBL] [Abstract][Full Text] [Related]
36. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
[TBL] [Abstract][Full Text] [Related]
37. Does oral alprazolam affect ventilation? A randomised, double-blind, placebo-controlled trial.
Carraro GE; Russi EW; Buechi S; Bloch KE
J Psychopharmacol; 2009 May; 23(3):322-7. PubMed ID: 18562435
[TBL] [Abstract][Full Text] [Related]
38. Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo.
Kaplan GB; Cotreau MM; Greenblatt DJ
J Pharm Pharmacol; 1992 Aug; 44(8):700-3. PubMed ID: 1359103
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
Orzack MH; Friedman L; Dessain E; Bird M; Beake B; McEachern J; Cole JO
Int J Addict; 1988 May; 23(5):449-67. PubMed ID: 3061941
[TBL] [Abstract][Full Text] [Related]
40. Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
Abernethy DR; Greenblatt DJ; Morse DS; Shader RI
Br J Clin Pharmacol; 1985 Jan; 19(1):51-7. PubMed ID: 2858217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
